Sep 29, 2009 - Precision BioSciences, Inc. today announced that the United States Patent and Trademark Office (PTO) has granted Precision's requests for inter partes reexamination of U.S. Patent Nos. 6,610,545 (the ˜545 patent) and 7,309,605 (the ˜605 patent), which Cellectis SA has asserted against Precision in litigation.
The details can be read here.
No comments:
Post a Comment